MedTrace Logo

Counterpulsation Reduces Infarct Size Pre-PCI for AMI

NCT00833612 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 339

Last updated 2011-06-27

No results posted yet for this study

Summary

Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.

Conditions

  • Acute Myocardial Infarction (AMI)

Interventions

DEVICE

Counterpulsation with IAB

IABC pre-reperfusion PCI

Sponsors & Collaborators

  • Duke University

    collaborator OTHER

  • Flinders Medical Centre

    collaborator OTHER_GOV

  • Datascope Corp.

    lead INDUSTRY

Principal Investigators

  • Magnus Ohman, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States
  • Australia
  • Belgium
  • France
  • Germany
  • India
  • Ireland
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00833612 on ClinicalTrials.gov